Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler Schwartz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|April 19, 2022
2021 in review: FDA approvals of new medicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Pharmaceutical Research|April 1, 2024
Antibiotic Development: Lessons from the Past and Future OpportunitiesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|November 4, 2020
Sources of innovation for new medicines: questions of sustainabilityMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|March 17, 2025
2024 in Review: FDA Approval of New MedicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|October 24, 2022
Monoclonal antibodies: Trends in therapeutic success and commercial focusMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|January 23, 2026
2025 in Review: Trends in Pharmaceutical InnovationMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|April 19, 2025
Target & Mechanism Selection in Pharmaceutical Innovation: A Source for Concern or Optimism?Michael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|September 14, 2020
2019 in review: FDA approvals of new medicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|July 12, 2021
2020 in review: FDA approvals of new medicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|December 4, 2022
Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focusMichael S Kinch, Zachary Kraft, Tyler Schwartz
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|April 19, 2022
2021 in review: FDA approvals of new medicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Pharmaceutical Research|April 1, 2024
Antibiotic Development: Lessons from the Past and Future OpportunitiesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|November 4, 2020
Sources of innovation for new medicines: questions of sustainabilityMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|March 17, 2025
2024 in Review: FDA Approval of New MedicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|October 24, 2022
Monoclonal antibodies: Trends in therapeutic success and commercial focusMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|January 23, 2026
2025 in Review: Trends in Pharmaceutical InnovationMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|April 19, 2025
Target & Mechanism Selection in Pharmaceutical Innovation: A Source for Concern or Optimism?Michael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|September 14, 2020
2019 in review: FDA approvals of new medicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|July 12, 2021
2020 in review: FDA approvals of new medicinesMichael S Kinch, Zachary Kraft, Tyler Schwartz
Drug Discovery Today|December 4, 2022
Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focusMichael S Kinch, Zachary Kraft, Tyler Schwartz
Pageof 2